| Year |
Citation |
Score |
| 2003 |
Badgwell BD, Valentino DJ, Jeffes EB, Dieffenbach K, Dulkanchainun SB, Yamamoto RS, Granger GA, Jakowatz JG, Carson WE. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunology, Immunotherapy : Cii. 52: 10-6. PMID 12536235 DOI: 10.1007/S00262-002-0330-2 |
0.305 |
|
| 1997 |
Jadus MR, Graf MR, Wepsic HT, Granger GA, Hiserodt JC. Development Of Systemic Immunity To Glioblastoma Multiforme Using Tumor Cells Genetically Engineered To Express The Membrane-Bound Isoform Of Macrophage-Colony Stimulating Factor Journal of Immunotherapy. 20: 419. DOI: 10.1097/00002371-199709000-00088 |
0.333 |
|
| 1996 |
Rose GS, Tocco LM, Granger GA, DiSaia PJ, Hamilton TC, Santin AD, Hiserodt JC. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat American Journal of Obstetrics and Gynecology. 175: 593-599. PMID 8828419 DOI: 10.1053/Ob.1996.V175.A73595 |
0.421 |
|
| 1996 |
Santin AD, Hiserodt JC, Fruehauf J, DiSaia PJ, Pecorelli S, Granger GA. Effects of irradiation on the expression of surface antigens in human ovarian cancer. Gynecologic Oncology. 60: 468-74. PMID 8774659 DOI: 10.1006/Gyno.1996.0075 |
0.405 |
|
| 1996 |
Katsura K, Park M, Gatanaga M, Yu EC, Takishima K, Granger GA, Gatanaga T. Identification of the proteolytic enzyme which cleaves human p75 TNF receptor in vitro. Biochemical and Biophysical Research Communications. 222: 298-302. PMID 8670199 DOI: 10.1006/Bbrc.1996.0738 |
0.389 |
|
| 1996 |
Choi SS, Gatanaga M, Granger GA, Gatanaga T. Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cellular Immunology. 170: 178-84. PMID 8660816 DOI: 10.1006/Cimm.1996.0150 |
0.41 |
|
| 1996 |
Santin AD, Hiserodt JC, DiSaia PJ, Pećorelli S, Granger GA. Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer. Gynecologic Oncology. 61: 403-8. PMID 8641623 DOI: 10.1006/Gyno.1996.0164 |
0.358 |
|
| 1996 |
Santin AD, Ioli GR, Hiserodt JC, Manetta A, Pecorelli S, DiSaia PJ, Granger GA. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules. American Journal of Obstetrics and Gynecology. 174: 633-40. PMID 8623798 DOI: 10.1016/S0002-9378(96)70441-6 |
0.331 |
|
| 1996 |
Santin AD, Rose GS, Hiserodt JC, Fruehauf J, Eck LM, Garcia RI, Schranz V, Disaia PJ, Pecorelli S, Granger GA. Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers International Journal of Cancer. 65: 688-694. PMID 8598323 DOI: 10.1002/(Sici)1097-0215(19960301)65:5<688::Aid-Ijc21>3.0.Co;2-2 |
0.398 |
|
| 1995 |
Santin AD, Ioli GR, Hiserodt JC, Rose GS, Graf MR, Lander JK, Disaia PJ, Pecorelli S, Granger GA. Development and in vitro characterization of a GM-CSF secreting human ovarian carcinoma tumor vaccine. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 5: 401-410. PMID 11578512 DOI: 10.1046/J.1525-1438.1995.05060401.X |
0.404 |
|
| 1995 |
Santin AD, Ioli GR, Hiserodt JC, Rose GS, Graf MR, Tocco LM, Lander JK, Eck LM, Burger RA, DiSaia PJ, Pecorelli S, Granger GA. Development and Characterization of an IL-4-Secreting Human Ovarian Carcinoma Cell Line Gynecologic Oncology. 58: 230-239. PMID 7622110 DOI: 10.1006/Gyno.1995.1216 |
0.327 |
|
| 1995 |
Burger RA, Grosen EA, Ioli GR, Van Eden ME, Park M, Berman ML, Manetta A, Disaia PJ, Granger GA, Gatanaga T. Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma Journal of Interferon and Cytokine Research. 15: 255-260. PMID 7584672 DOI: 10.1089/Jir.1995.15.255 |
0.346 |
|
| 1994 |
Burger RA, Grosen EA, Ioli GR, Van Eden ME, Brightbill HD, Gatanaga M, DiSaia PJ, Granger GA, Gatanaga T. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro. Gynecologic Oncology. 55: 294-303. PMID 7959299 DOI: 10.1006/Gyno.1994.1293 |
0.354 |
|
| 1993 |
Jeffes EW, Beamer YB, Jacques S, Silberman RS, Vayuvegula B, Gupta S, Coss JS, Yamamoto RS, Granger GA. Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA. Journal of Neuro-Oncology. 15: 141-55. PMID 8509819 DOI: 10.1007/Bf01053935 |
0.358 |
|
| 1993 |
Scannell G, Waxman K, Kaml GJ, Ioli G, Gatanaga T, Yamamoto R, Granger GA. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. The Journal of Surgical Research. 54: 281-5. PMID 8392647 DOI: 10.1006/Jsre.1993.1044 |
0.359 |
|
| 1993 |
Hosszufalusi N, Chan E, Teruya M, Takei S, Granger G, Charles MA. Quantitative phenotypic and functional analyses of islet immune cells before and after diabetes onset in the BB rat Diabetologia. 36: 1146-1154. PMID 8270129 DOI: 10.1007/Bf00401059 |
0.423 |
|
| 1993 |
Abe Y, Van Eden M, Gatanaga M, Wang FI, Brightbill HD, Granger GA, Gatanaga T. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro. Lymphokine and Cytokine Research. 12: 279-83. PMID 8260536 |
0.334 |
|
| 1993 |
Abe Y, Gatanaga M, Osuka Y, Kimura S, Burger RA, Granger GA, Gatanaga T. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. Journal of Immunology (Baltimore, Md. : 1950). 150: 5070-9. PMID 8098725 |
0.328 |
|
| 1992 |
Lucci JA, Manetta A, Cappuccini F, Ininns EK, Dett CA, DiSaia P, Yamamoto RS, Berman ML, Soopikian J, Granger GA. Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. Gynecologic Oncology. 45: 129-35. PMID 1592279 DOI: 10.1016/0020-7292(93)90395-D |
0.443 |
|
| 1992 |
Abe Y, Horiuchi A, Osuka Y, Kimura S, Granger GA, Gatanaga T. Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro. Lymphokine and Cytokine Research. 11: 115-21. PMID 1581418 |
0.351 |
|
| 1992 |
Cappuccini F, Lucci JA, Dett CA, Gatanaga M, Ininns EK, Gatanaga T, Yamamoto RS, Manetta A, DiSaia PJ, Granger GA. Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice. Gynecologic Oncology. 46: 163-9. PMID 1500017 DOI: 10.1016/0090-8258(92)90249-I |
0.429 |
|
| 1992 |
Innins EK, Gatanaga M, Van Eden M, Knudsen KL, Granger GA, Gatanaga T. The autocrine role of tumor necrosis factor in the proliferation and functional differentiation of human lymphokine-activated T killer cells (T-LAK) in vitro. Cytokine. 4: 391-6. PMID 1421001 DOI: 10.1016/1043-4666(92)90083-4 |
0.439 |
|
| 1992 |
Hosszufalusi N, Chan E, Granger G, Charles MA. Quantitative analyses comparing all major spleen cell phenotypes in BB and normal rats: autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals. Journal of Autoimmunity. 5: 305-318. PMID 1388637 DOI: 10.1016/0896-8411(92)90145-G |
0.375 |
|
| 1992 |
Ininns EK, Gatanaga M, Cappuccini F, Dett CA, Yamamoto RS, Granger GA, Gatanaga T. Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro. Endocrinology. 130: 1852-6. PMID 1312427 DOI: 10.1210/Endo.130.4.1312427 |
0.348 |
|
| 1992 |
Grosen E, Berman M, DiSaia P, Manetta A, Granger G. Blocking factors (BF) and soluble receptors for tumor necrosis factor (TNF) and lymphotoxin (LT) in the cell-free ascites and tumor culture supernatants of patients with gynecologic malignancies Gynecologic Oncology. 45: 90. DOI: 10.1016/0090-8258(92)90554-V |
0.334 |
|
| 1991 |
Carson WE, Jakowatz JG, Yamamoto R, Fitzgerald T, Gupta S, Vayuvegula B, Lucci JA, Beckman MT, Dulkanchainun S, Granger GA. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 10: 131-40. PMID 2043593 DOI: 10.1097/00002371-199104000-00007 |
0.415 |
|
| 1991 |
Yamamoto RS, Coss J, Vayuvegula B, Gupta S, Beamer Y, Jacques S, Jeffes EW, Carson WE, Jakowatz J, Granger GA. Generation of stimulated, lymphokine activated T killer (T-LAK) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma. Journal of Immunological Methods. 137: 225-35. PMID 2013699 DOI: 10.1016/0022-1759(91)90028-E |
0.453 |
|
| 1991 |
Hwang CD, Gatanaga M, Innins EK, Yamamoto RS, Granger GA, Gatanaga T. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro. Proceedings. Biological Sciences. 245: 115-9. PMID 1682934 DOI: 10.1098/Rspb.1991.0096 |
0.343 |
|
| 1991 |
Yousefi S, Vaziri N, Carandang G, Le W, Yamamoto R, Granger G, Ocariz J, Cesario T. The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. British Journal of Cancer. 64: 243-246. PMID 1679996 DOI: 10.1038/Bjc.1991.284 |
0.381 |
|
| 1991 |
Gatanaga T, Hwang CD, Gatanaga M, Cappuccini F, Yamamoto RS, Granger GA. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cellular Immunology. 138: 1-10. PMID 1655285 DOI: 10.1016/0008-8749(91)90127-W |
0.403 |
|
| 1990 |
Manetta A, Lucci J, Soopikian J, Granger G, Berman ML, DiSaia PJ. In vitro cytotoxicity of human recombinant tumor necrosis factor α in association with radiotherapy in a human ovarian carcinoma cell line Gynecologic Oncology. 38: 200-202. PMID 2387537 DOI: 10.1016/0090-8258(90)90041-I |
0.38 |
|
| 1990 |
Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proceedings of the National Academy of Sciences of the United States of America. 87: 8781-4. PMID 2174164 DOI: 10.1073/Pnas.87.22.8781 |
0.389 |
|
| 1990 |
Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV. Molecular cloning and expression of a receptor for human tumor necrosis factor Cell. 61: 361-370. PMID 2158863 DOI: 10.1016/0092-8674(90)90816-W |
0.364 |
|
| 1990 |
Knauer MF, Longmuir KJ, Yamamoto RS, Fitzgerald TP, Granger GA. Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: phospholipase activation and deacylation of specific-membrane phospholipids. Journal of Cellular Physiology. 142: 469-79. PMID 2107184 DOI: 10.1002/Jcp.1041420305 |
0.43 |
|
| 1989 |
Jeffes EW, Ininns EK, Schmitz KL, Yamamoto RS, Dett CA, Granger GA. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis and Rheumatism. 32: 1148-52. PMID 2789046 DOI: 10.1002/Anr.1780320914 |
0.351 |
|
| 1988 |
Cohen R, Contino M, Hensen DK, Terem TM, Ibsen KI, Granger GA, Wile AG. Heterogeneity of soluble suppressor factors in rat malignant ascites. Oncology. 45: 230-5. PMID 3368199 DOI: 10.1159/000226567 |
0.311 |
|
| 1988 |
Granger GA, Masunaka I, Averbook B, Kobayashi M, Fitzgerald M, Yamamoto R. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice. Journal of Biological Response Modifiers. 7: 488-97. PMID 3263472 |
0.373 |
|
| 1987 |
Averbook BJ, Yamamoto RS, Ulich TR, Jeffes EW, Masunaka I, Granger GA. Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. Journal of Clinical Immunology. 7: 333-40. PMID 3611300 DOI: 10.1007/Bf00915556 |
0.336 |
|
| 1987 |
Fitzgerald MT, Longmuir KJ, Granger GA. Phospholipases are activated during cell destruction by human alpha-lymphotoxin in vitro. Lymphokine Research. 6: 319-24. PMID 3501507 |
0.323 |
|
| 1986 |
Yamamoto RS, Ware CF, Granger GA. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. Journal of Immunology (Baltimore, Md. : 1950). 137: 1878-84. PMID 2943806 |
0.627 |
|
| 1985 |
Armstrong CA, Klostergaard J, Granger GA. Isolation and Initial Characterization of Tumoricidal Monokine(s) From the Human Monocytic Leukemia Cell Line THP-1 Journal of the National Cancer Institute. 74: 1-9. DOI: 10.1093/Jnci/74.1.1 |
0.411 |
|
| 1984 |
Wile AG, Hensen D, Nahabedian M, Ibsen KH, Granger GA. Soluble suppressor factors elaborated in experimental malignant ascites. Cellular Immunology. 86: 347-53. PMID 6610480 DOI: 10.1016/0008-8749(84)90389-7 |
0.4 |
|
| 1984 |
Granger GA, Klostergaard J, Yamamoto RS, Devlin J, Orr SL, McGriff D, Miner KM. Lymphotoxins - a multicomponent system of growth inhibitory and cell-lytic glycoproteins. Advances in Experimental Medicine and Biology. 172: 205-17. PMID 6610289 DOI: 10.1007/978-1-4615-9376-8_12 |
0.46 |
|
| 1984 |
Klostergaard J, Reidarson TH, Granger GA. Purification of murine macrophage cytotoxin (MCT). Journal of Leukocyte Biology. 35: 229-38. PMID 6584519 DOI: 10.1002/Jlb.35.2.229 |
0.313 |
|
| 1984 |
Devlin JJ, Klostergaard J, Granger GA. Isolation and identification of an alpha 2 subclass lymphotoxin (LT) subunit from the high-molecular-weight (complex) human LT class. Cellular Immunology. 88: 297-308. PMID 6333278 DOI: 10.1016/0008-8749(84)90163-1 |
0.302 |
|
| 1983 |
Weitzen ML, Innins E, Yamamoto RS, Granger GA. Inhibition of human NK-induced cell lysis and soluble cell-lytic molecules with anti-human LT antisera and various saccharides. Cellular Immunology. 77: 42-51. PMID 6601529 DOI: 10.1016/0008-8749(83)90005-9 |
0.505 |
|
| 1983 |
Weitzen ML, Yamamoto RS, Granger GA. Identification of human lymphocyte-derived lymphotoxins with binding and cell-lytic activity on NK-sensitive cell lines in vitro. Cellular Immunology. 77: 30-41. PMID 6601528 DOI: 10.1016/0008-8749(83)90004-7 |
0.472 |
|
| 1983 |
Miner KM, Klostergaard J, Granger GA, Nicolson GL. Differences in Cytotoxic Effects of Activated Murine Peritoneal Macrophages and J774 Monocytic Cells on Metastatic Variants of B16 Melanoma Journal of the National Cancer Institute. 70: 717-724. DOI: 10.1093/Jnci/70.4.717 |
0.451 |
|
| 1982 |
Korotzer TI, Page RC, Granger GA, Rabinovitch PS. Regulation of growth of human diploid fibroblasts by factors elaborated by activated lymphoid cells. Journal of Cellular Physiology. 111: 247-54. PMID 7096453 DOI: 10.1002/Jcp.1041110305 |
0.305 |
|
| 1982 |
Devlin JJ, Phaneuf JD, Granger GA. Inhibition of human lectin-dependent cell-mediated cytotoxicity, natural killer-like cytotoxicity, and cytotoxic T-lymphocyte-mediated cytolysis by xenoantisera raised against concanavalin A-stimulated human lymphocytes. Cellular Immunology. 68: 64-74. PMID 6979401 DOI: 10.1016/0008-8749(82)90090-9 |
0.504 |
|
| 1982 |
Klostergaard J, Long S, Granger GA. Purification of human alpha-light class lymphotoxin to electrophoretic homogeneity. Molecular Immunology. 18: 1049-54. PMID 6977700 DOI: 10.1016/0161-5890(81)90020-1 |
0.411 |
|
| 1982 |
Klostergaard J, Granger GA. Human lymphotoxins: purification to electrophoretic homogeneity of the alpha H receptor-bearing class. Molecular Immunology. 18: 455-8. PMID 6975877 DOI: 10.1016/0161-5890(81)90109-7 |
0.371 |
|
| 1982 |
Krassner SM, Granger B, Morrow C, Granger G. In vitro release of lymphotoxin by spleen cells from C3H/HEJ and C57BL/6 mice infected with Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene. 31: 1080-1089. PMID 6816078 DOI: 10.4269/Ajtmh.1982.31.1080 |
0.348 |
|
| 1982 |
Reidarson TH, Granger GA, Klostergaard J. Inducible Macrophage Cytotoxins. II. Tumor Lysis Mechanism Involving Target Cell-Binding Proteases Journal of the National Cancer Institute. 69: 889-894. DOI: 10.1093/Jnci/69.4.889 |
0.453 |
|
| 1982 |
Reidarson TH, Levy WE, Klostergaard J, Granger GA. Inducible Macrophage Cytotoxins. I. Biokinetics of Activation and Release In Vitro Journal of the National Cancer Institute. 69: 879-887. DOI: 10.1093/Jnci/69.4.879 |
0.421 |
|
| 1982 |
Yamamoto RS, Weitzen ML, Miner KM, Devlin JJ, Granger GA. Role Of Lymphotoxins In Natural Cytotoxicity Nk Cells and Other Natural Effector Cells. 969-976. DOI: 10.1016/B978-0-12-341360-4.50144-X |
0.448 |
|
| 1982 |
Devlin JJ, Klostergaard J, Yamamoto RS, Granger GA. Biochemical studies of high molecular weight complex lymphotoxin and evidence that it is involved in cytotoxic T-cell mediated lysis Cellular Immunology. 70: 398. DOI: 10.1016/0008-8749(82)90394-X |
0.344 |
|
| 1981 |
Ware CF, Chauvenet PH, Duffey PS, Granger GA. Inhibition of the lytic phase of murine t-cell-mediated alloimmune cytotoxicity by a rat antiactivated t-cell antiserum. Cellular Immunology. 59: 289-300. PMID 6974600 DOI: 10.1016/0008-8749(81)90410-X |
0.631 |
|
| 1981 |
Ware CF, Granger GA. Mechanisms of lymphocyte-mediated cytotoxicity. III. Characterization of the mechanism of inhibition of the human alloimmune lymphocyte-mediated cytotoxic reaction by polyspecific anti-lymphotoxin sera in vitro. Journal of Immunology (Baltimore, Md. : 1950). 126: 1934-40. PMID 6971314 |
0.524 |
|
| 1981 |
Devlin JJ, Yamamoto RS, Granger GA. Stabilization and functional studies of high-molecular-weight murine lymphotoxins. Cellular Immunology. 61: 22-31. PMID 6790176 DOI: 10.1016/0008-8749(81)90350-6 |
0.441 |
|
| 1981 |
Ware CF, Granger GA. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro Journal of Immunology. 126: 1919-1926. PMID 6452481 |
0.583 |
|
| 1981 |
Klostergaard J, Yamamoto RS, Granger GA. Human and murine lymphotoxins as a multicomponent system: progress in purification of the human alpha L component. Molecular Immunology. 17: 613-23. PMID 6163959 DOI: 10.1016/0161-5890(80)90159-5 |
0.465 |
|
| 1981 |
Ware CF, Harris PC, Granger GA. Mechanisms of lymphocyte-mediated cytotoxicity. II. Biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro Journal of Immunology. 126: 1927-1933. PMID 6163823 |
0.591 |
|
| 1980 |
Toth MK, Granger GA. The human lymphotoxin system--VI. Identification of various saccharides on LT molecules and their contribution to cytotoxicity and charge heterogeneity. Molecular Immunology. 16: 671-9. PMID 316857 DOI: 10.1016/0161-5890(79)90007-5 |
0.361 |
|
| 1979 |
Hiserodt JC, Ford SC, Harris PC, Granger GA. The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes Cellular Immunology. 47: 32-45. PMID 315825 DOI: 10.1016/0008-8749(79)90312-5 |
0.476 |
|
| 1979 |
Fair DS, Jeffes EW, Granger GA. Release of LT molecules with restricted physical heterogeneity by a continuous human lymphoid cell line in vitro. Molecular Immunology. 16: 185-92. PMID 314928 DOI: 10.1016/0161-5890(79)90144-5 |
0.452 |
|
| 1979 |
Ware CF, Granger GA. A physicochemical and immunologic comparison of the cell growth inhibitory activity of human lymphotoxins and interferons in vitro. Journal of Immunology (Baltimore, Md. : 1950). 122: 1763-70. PMID 312850 |
0.564 |
|
| 1979 |
Lundak RL, Runge PE, Granger GA. Separation of functional subpopulations of murine and human lymphoid cells on colloidal silica density gradients. I. Preparation of the Ludox AM gradient material and characterization of separation capacities. Journal of Immunological Methods. 28: 277-92. PMID 225386 DOI: 10.1016/0022-1759(79)90194-7 |
0.37 |
|
| 1979 |
Yamamoto RS, Hiserodt JC, Granger GA. The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s). Cellular Immunology. 45: 261-75. PMID 157226 DOI: 10.1016/0008-8749(79)90387-3 |
0.476 |
|
| 1979 |
Hiserodt JC, Yamamoto RS, Granger GA. The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro. Cellular Immunology. 41: 380-96. PMID 83202 DOI: 10.1016/0008-8749(78)90235-6 |
0.446 |
|
| 1978 |
Granger GA, Yamamoto RS, Fair DS, Hiserodt JC. The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cellular Immunology. 38: 388-402. PMID 307989 DOI: 10.1016/0008-8749(78)90069-2 |
0.375 |
|
| 1978 |
Hiserodt JC, Yamamoto RS, Granger GA. The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules. Cellular Immunology. 38: 417-33. PMID 79448 DOI: 10.1016/0008-8749(78)90071-0 |
0.373 |
|
| 1978 |
Yamamoto RS, Hiserodt JC, Lewis JE, Carmack CE, Granger GA. The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro. Cellular Immunology. 38: 403-16. PMID 79447 DOI: 10.1016/0008-8749(78)90070-9 |
0.466 |
|
| 1977 |
Lundak RL, Kaplan MS, Raidt DJ, Hronis TS, Granger GA. Cellular immune response in vitro: I. A requirement for time-dependent T-lymphocyte cell division of cytotoxic cells in the allogeneic response. Journal of Surgical Oncology. 8: 373-81. PMID 1086928 DOI: 10.1002/Jso.2930080504 |
0.454 |
|
| 1977 |
Lewis JE, Carmack CE, Yamamoto R, Granger GA. Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (alpha) and unstable (beta) lymphotoxins released in vitro by activated human lymphocytes. Journal of Immunological Methods. 14: 163-76. PMID 557069 DOI: 10.1016/0022-1759(77)90006-0 |
0.378 |
|
| 1977 |
Hiserodt JC, Ware CF, Harris PC, Granger GA. Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro Cellular Immunology. 34: 326-339. PMID 303942 DOI: 10.1016/0008-8749(77)90255-6 |
0.619 |
|
| 1977 |
Hiserodt JC, Ware CF, Granger GA. Identification Of Lymfhotoxin (Lt) As The Mediator Of Direct Cytolys Is Of L-929 Cells By Mitogen Activated Human Lymphocytes In Vitro Regulatory Mechanisms in Lymphocyte Activation. 551-553. DOI: 10.1016/B978-0-12-458050-3.50089-8 |
0.643 |
|
| 1976 |
Hiserodt JC, Granger GA. In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes. Cellular Immunology. 26: 211-6. PMID 1086143 DOI: 10.1016/0008-8749(76)90365-8 |
0.395 |
|
| 1976 |
Hiserodt JC, Prieur AM, Granger GA. In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cellular Immunology. 24: 277-88. PMID 1084788 DOI: 10.1016/0008-8749(76)90212-4 |
0.415 |
|
| 1976 |
Lewis AE, Yamamoto R, Carmack C, Lundak RL, Granger GA. Lymphocyte effector molecules: an vitro production method for obtaining liter volumes of supernatants from mitogen-stimulated human lymphocytes. Journal of Immunological Methods. 11: 371-83. PMID 1084376 DOI: 10.1016/0022-1759(76)90131-9 |
0.405 |
|
| 1976 |
Fair D, Jeffes E, Ware C, Granger G. The PGLC-33H cell line appears to secrete only a-Lymphotoxin Cellular Immunology. 27: 355. DOI: 10.1016/0008-8749(76)90308-7 |
0.543 |
|
| 1976 |
Hiserod J, Ware C, Ford S, Granger G. The relationship of LT synthesis, expression of the cell membrane, secretion, and target cell cytolysis in mitogen-activated human lymphocyte cultures Cellular Immunology. 27: 342. DOI: 10.1016/0008-8749(76)90270-7 |
0.435 |
|
| 1975 |
Daynes RA, Granger GA. The regulation of lymphotoxin release from stimulated human lymphocyte cultures: the requirement for continual mitogen stimulation. Cellular Immunology. 12: 252-62. PMID 4549191 DOI: 10.1016/0008-8749(74)90077-X |
0.384 |
|
| 1975 |
Kramer SL, Granger GA. The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte. Cellular Immunology. 15: 57-68. PMID 1078544 DOI: 10.1016/0008-8749(75)90164-1 |
0.453 |
|
| 1975 |
Prieur AM, Granger GA. The effect of agents which modulate levels of the cyclic nucleotides on human lymphotoxin secretion and activity in vitro. Transplantation. 20: 331-7. PMID 169610 DOI: 10.1097/00007890-197510000-00010 |
0.401 |
|
| 1975 |
Kramer JJ, Granger GA. Relationship of lymphotoxin secretion and DNA synthesis in the human mixed lymphocytes reaction in vitro. Cellular Immunology. 17: 192-201. PMID 123828 DOI: 10.1016/S0008-8749(75)80019-0 |
0.409 |
|
| 1974 |
Hessinger DA, Daynes RA, Granger GA. Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction. Proceedings of the National Academy of Sciences of the United States of America. 70: 3082-6. PMID 4544711 DOI: 10.1073/Pnas.70.11.3082 |
0.421 |
|
| 1973 |
Williams TW, Granger GA. Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction. Cellular Immunology. 6: 171-85. PMID 4693834 DOI: 10.1016/0008-8749(73)90020-8 |
0.481 |
|
| 1973 |
Kramer JJ, Granger GA. In vitro mechanism of human lymphotoxin action: destruction of nondividing target cells. Cellular Immunology. 6: 153-7. PMID 4684523 DOI: 10.1016/0008-8749(73)90016-6 |
0.394 |
|
| 1973 |
Shacks SJ, Chiller J, Granger GA. Studies on in vitro models of cellular immunity: the role of T and B cells in the secretion of lymphotoxin. Cellular Immunology. 7: 313-21. PMID 4540898 DOI: 10.1016/0008-8749(73)90253-0 |
0.432 |
|
| 1972 |
Kolb WP, Granger GA. Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin. Cellular Immunology. 1: 122-32. PMID 5535593 DOI: 10.1016/0008-8749(70)90065-1 |
0.496 |
|
| 1972 |
Kramer JJ, Granger GA. The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages. Cellular Immunology. 3: 88-100. PMID 5009049 DOI: 10.1016/0008-8749(72)90229-8 |
0.467 |
|
| 1972 |
Kramer JJ, Granger GA. An improved in vitro assay for lymphotoxin. Cellular Immunology. 3: 144-9. PMID 5009045 DOI: 10.1016/0008-8749(72)90235-3 |
0.396 |
|
| 1971 |
Pauley GB, Granger GA, Krassner SM. Characterization of a natural agglutinin present in the hemolymph of the California sea hare, Aplysia californica. Journal of Invertebrate Pathology. 18: 207-18. PMID 5092840 DOI: 10.1016/0022-2011(71)90148-0 |
0.341 |
|
| 1969 |
Kolb WP, Granger GA. Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proceedings of the National Academy of Sciences of the United States of America. 61: 1250-5. PMID 5249808 DOI: 10.1073/Pnas.61.4.1250 |
0.381 |
|
| 1969 |
Granger GA, Shacks SJ, Williams TW, Kolb WP. Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature. 221: 1155-7. PMID 4975283 DOI: 10.1038/2211155A0 |
0.457 |
|
| 1968 |
Williams TW, Granger GA. Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature. 219: 1076-7. PMID 5673378 DOI: 10.1038/2191076A0 |
0.377 |
|
| 1968 |
Granger GA, Williams TW. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature. 218: 1253-4. PMID 5656652 DOI: 10.1038/2181253A0 |
0.485 |
|
| 1968 |
Taylor MW, Buck CA, Granger GA, Holland JJ. Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. Journal of Molecular Biology. 33: 809-28. PMID 4882617 DOI: 10.1016/0022-2836(68)90321-5 |
0.332 |
|
| 1967 |
Buck CA, Granger GA, Holland JJ. Initiation and completion of mitosis in HeLa cells in the absence of protein synthesis. Currents in Modern Biology. 1: 9-13. PMID 6059310 DOI: 10.1016/0303-2647(67)90014-7 |
0.319 |
|
| 1967 |
Buck CA, Granger GA, Taylor MW, Holland JJ. Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology. 33: 36-46. PMID 4292343 DOI: 10.1016/0042-6822(67)90091-8 |
0.341 |
|
| 1966 |
Granger GA, Weiser RS. Homograft target cells: contact destruction in vitro by immune macrophages. Science (New York, N.Y.). 151: 97-9. PMID 5325461 DOI: 10.1126/Science.151.3706.97 |
0.587 |
|
| 1965 |
GRANGER GA, WEISER RS, HOLMES B. THE PATHOGENESIS OF ACUTE ALLOGENEIC DISEASE IN MICE STUDIED BY PARABIOSIS. Transplantation. 3: 524-30. PMID 14339510 DOI: 10.1097/00007890-196507000-00008 |
0.514 |
|
| 1965 |
WEISER RS, GRANGER GA, BROWN W, BAKER P, JUTILA J, HOLMES B. PRODUCTION OF ACUTE ALLOGENEIC DISEASE IN MICE. Transplantation. 3: 10-21. PMID 14251679 |
0.515 |
|
| 1964 |
GRANGER GA, WEISER RS. HOMOGRAFT TARGET CELLS: SPECIFIC DESTRUCTION IN VITRO BY CONTACT INTERACTION WITH IMMUNE MACROPHAGES. Science (New York, N.Y.). 145: 1427-9. PMID 14172631 DOI: 10.1126/Science.145.3639.1427 |
0.632 |
|
| Show low-probability matches. |
